Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine

By Dagan R.   Greenberg D.   Goldenbertg-Gehtman P.   Vidor E.   Briantais P.   Pinsk V.   Athias O.   Dumas R.  

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 1919-1925

Elsevier

Access to resources Recommend Favorite

High immunogenicity and good tolerability of a new hepatitis A vaccine candidate

By Langer B.C.A.   Lovestad A.   Frosner G.G.  

Vaccine, Vol. 14, Iss. 12, 1996-08 ,pp. : 1089-1091

Elsevier

Access to resources Recommend Favorite

Immunogenicity of combined hepatitis A and B vaccine in elderly persons

By Wolters B.   Junge U.   Dziuba S.   Roggendorf M.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3623-3628

Elsevier

Access to resources Recommend Favorite

Immunogenicity and safety of a new inactivated hepatitis A vaccine: a clinical trial with comparison of administration route

By Fisch A.   Cadilhac P.   Vidor E.   Prazuck T.   Dublanchet A.   Lafaix C.  

Vaccine, Vol. 14, Iss. 12, 1996-08 ,pp. : 1132-1136

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system

By Thoelen S.   Van Damme P.   Mathei C.   Leroux-Roels G.   Desombere I.   Safary A.   Vandepapeliere P.   Slaoui M.   Meheus A.  

Vaccine, Vol. 16, Iss. 7, 1998-04 ,pp. : 708-714

Elsevier

Access to resources Recommend Favorite